Get Email Alerts
Dr. Simons-Morton In The News
March 14, 2010
Landmark ACCORD Trial Finds Intensive Blood Pressure and Combination Lipid Therapies do not Reduce Combined Cardiovascular Events in Adults with Diabetes
Lowering blood pressure to normal levels – below currently recommended levels – did not significantly reduce the combined risk of fatal or nonfatal cardiovascular disease events in adults with type 2 diabetes who were at especially high risk for cardiovascular disease events, according to new results from the landmark Action to Control Cardiovascular Risk in Diabetes (ACCORD) clinical trial.
February 6, 2008
For Safety, NHLBI Changes Intensive Blood Sugar Treatment Strategy in Clinical Trial of Diabetes and Cardiovascular Disease
The National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health has stopped one treatment within a large, ongoing North American clinical trial of diabetes and cardiovascular disease 18 months early due to safety concerns after review of available data, although the study will continue.
December 17, 2001
NHLBI Study Finds DASH Diet And Reduced Sodium Lowers Blood Pressure For All
The DASH diet plus reduced dietary sodium lowers blood pressure for all persons, according to the first detailed subgroup analysis of the DASH study results. The Dietary Approaches to Stop Hypertension study was supported by the National Heart, Lung, and Blood Institute (NHLBI).
August 7, 2001
NHLBI Study Finds Brief Counseling By Health Professionals Boosts Patients' Physical Fitness
Just 3 hours of advice and counseling by doctors and other health care professionals over 2 years can boost sedentary adults' physical fitness, according to a new study sponsored by the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health.
November 30, 1999
Sodium Intake Linked to Increased Risk of Heart Disease Death in Overweight Persons
A diet high in sodium increases the risk of heart disease-related mortality in overweight individuals, according to a study published in the December 1 issue of the Journal of the American Medical Association (JAMA).
September 1, 1999
Diabetes Mellitus: A Major Risk Factor for Cardiovascular Disease
The National Heart, Lung, and Blood Institute (NHLBI) and National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health (NIH) have collaborated with three leading private health organizations on a major public health statement to alert physicians, patients, and the general public to the increasing significance of diabetes mellitus as a major risk factor for cardiovascular disease.
January 26, 1999
Simple Lifestyle Changes Boost Physical Activity/Cardiovascular Health
Small lifestyle changes that increase moderate-intensity physical activity are as effective as a structured exercise program in improving long-term cardiorespiratory fitness and blood pressure, according to a study supported by the National Heart, Lung, and Blood Institute (NHLBI).
June 17, 1998
First Federal Obesity Clinical Guidelines Released
The first Federal guidelines on the identification, evaluation, and treatment of overweight and obesity in adults were released today by the National Heart, Lung, and Blood Institute (NHLBI), in cooperation with the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
June 3, 1998
Statement on First Federal Obesity Clinical Guidelines
The first Federal guidelines on the identification, evaluation, and treatment of overweight and obesity in adults are scheduled to be released on June 17 by the National Heart, Lung, and Blood Institute (NHLBI), in cooperation with the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
November 6, 1997
New High Blood Pressure Guidelines Released by the NHLBI
New physician guidelines for the prevention and treatment of high blood pressure were released today by the National Heart, Lung, and Blood Institute (NHLBI). The guidelines, approved by the Coordinating Committee of the NHLBI's National High Blood Pressure Education Program, contain updated treatment strategies, including a system of stratifying patients into risk groups and the idea of compelling indications for certain antihypertensive medications.
Twitter
Facebook
YouTube